An overview of fecal sample preparation for global metabolic profiling.

The global metabolic profiling of feces represents a challenge for both analytical chemistry and biochemistry standpoints. As a specimen, feces is complex, not homogenous and rich in macromolecules and particulate, non-digested, matter that can present problems for analytical systems. Further to this, the composition of feces is highly dependent on short-term dietary factors whilst also representing the primary specimen where co-metabolism of the host organism and the gut-microbiota is expressed. Thus the presence and the content of metabolites can be a result of host metabolism, gut microbiota metabolism or co-metabolism. Successful sample preparation and metabolite analysis require that the methodology applied for sample preparation is adequate to compensate for the highly variable nature of the sample in order to generate useful data and provide insight to ongoing biochemical processes, thereby generating hypotheses. The current practices for processing fecal samples for global metabolic profiling are described with emphasis on critical aspects in sample preparation: e.g., homogenization, filtration, centrifugation, solvent extraction and so forth and also conditions/parameter selection are discussed. The different methods applied for feces processing prior to metabolite analysis are summarized and illustrated using selected examples to highlight the effect of sample preparation on the metabolic profile obtained.

[1]  Huiru Tang,et al.  Age-related topographical metabolic signatures for the rat gastrointestinal contents. , 2012, Journal of proteome research.

[2]  Ian D Wilson,et al.  Analytical strategies in metabonomics. , 2007, Journal of proteome research.

[3]  Johan Auwerx,et al.  The metabolic footprint of aging in mice , 2011, Scientific reports.

[4]  R. Trengove,et al.  Metabolomic Profiling of Faecal Extracts from Cryptosporidium parvum Infection in Experimental Mouse Models , 2013, PloS one.

[5]  Ian D Wilson,et al.  Hydrophilic interaction chromatography coupled to MS for metabonomic/metabolomic studies. , 2010, Journal of separation science.

[6]  Huiru Tang,et al.  An optimised sample preparation method for NMR-based faecal metabonomic analysis. , 2010, The Analyst.

[7]  J. Lindon,et al.  'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. , 1999, Xenobiotica; the fate of foreign compounds in biological systems.

[8]  Kirill Veselkov,et al.  Species variation in the fecal metabolome gives insight into differential gastrointestinal function. , 2008, Journal of proteome research.

[9]  P. Galan,et al.  Metabolite analysis of human fecal water by gas chromatography/mass spectrometry with ethyl chloroformate derivatization. , 2009, Analytical biochemistry.

[10]  Junfang Wu,et al.  Gut microbiota composition modifies fecal metabolic profiles in mice. , 2013, Journal of proteome research.

[11]  Michael A Kennedy,et al.  NMR‐based metabonomics analysis of mouse urine and fecal extracts following oral treatment with the broad‐spectrum antibiotic enrofloxacin (Baytril) , 2009, Magnetic resonance in chemistry : MRC.

[12]  Georgios Theodoridis,et al.  UPLC-MS-based analysis of human plasma for metabonomics using solvent precipitation or solid phase extraction. , 2009, Journal of proteome research.

[13]  F. Marini,et al.  Fecal and urinary NMR-based metabolomics unveil an aging signature in mice , 2014, Experimental Gerontology.

[14]  R. Trengove,et al.  Development of an untargeted metabolomics method for the analysis of human faecal samples using Cryptosporidium-infected samples. , 2012, Molecular and biochemical parasitology.

[15]  E. K. Kemsley,et al.  Metabolomics of fecal extracts detects altered metabolic activity of gut microbiota in ulcerative colitis and irritable bowel syndrome. , 2011, Journal of proteome research.

[16]  Lanjuan Li,et al.  Fecal metabolome profiling of liver cirrhosis and hepatocellular carcinoma patients by ultra performance liquid chromatography-mass spectrometry. , 2011, Analytica chimica acta.

[17]  H. Ashrafian,et al.  Understanding the role of gut microbiome-host metabolic signal disruption in health and disease. , 2011, Trends in microbiology.

[18]  H. Gaskins,et al.  Impact of the intestinal microbiota on the development of mucosal defense. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[19]  J. Pettersson,et al.  NMR metabolomic analysis of fecal water from subjects on a vegetarian diet. , 2008, Biological & pharmaceutical bulletin.

[20]  R Somorjai,et al.  Detecting colorectal cancer by 1H magnetic resonance spectroscopy of fecal extracts , 2009, NMR in biomedicine.

[21]  A. Cheema,et al.  Metabolomics of Human Intestinal Transplant Rejection , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[22]  J. Utzinger,et al.  Metabonomic investigations of age- and batch-related variations in female NMRI mice using proton nuclear magnetic resonance spectroscopy. , 2013, Molecular bioSystems.

[23]  E. Want,et al.  Liquid chromatography-mass spectrometry based global metabolite profiling: a review. , 2012, Analytica chimica acta.

[24]  Ron Wehrens,et al.  LC-MS based global metabolite profiling of grapes: solvent extraction protocol optimisation , 2011, Metabolomics.

[25]  J. Goedert,et al.  Fecal metabolomics: assay performance and association with colorectal cancer. , 2014, Carcinogenesis.

[26]  E. Pujos-Guillot,et al.  Development of a quantitative metabolomic approach to study clinical human fecal water metabolome based on trimethylsilylation derivatization and GC/MS analysis. , 2010, Analytical chemistry.

[27]  Ian C. P. Smith,et al.  MR metabolomics of fecal extracts: applications in the study of bowel diseases , 2009, Magnetic resonance in chemistry : MRC.

[28]  M. Orešič,et al.  Data processing for mass spectrometry-based metabolomics. , 2007, Journal of chromatography. A.

[29]  M. Fairchok,et al.  Lactobacillus Sepsis Associated With Probiotic Therapy , 2005, Pediatrics.

[30]  J. Lindon,et al.  NMR‐based metabonomic approaches for evaluating physiological influences on biofluid composition , 2005, NMR in biomedicine.

[31]  Robert S Plumb,et al.  Current practice of liquid chromatography-mass spectrometry in metabolomics and metabonomics. , 2014, Journal of pharmaceutical and biomedical analysis.

[32]  I. Wilson,et al.  Evaluation of the repeatability of ultra-performance liquid chromatography-TOF-MS for global metabolic profiling of human urine samples. , 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[33]  J. Utzinger,et al.  Chemometric analysis of biofluids from mice experimentally infected with Schistosoma mansoni , 2011, Parasites & Vectors.

[34]  M. D. Luque de Castro,et al.  Metabolomics analysis I. Selection of biological samples and practical aspects preceding sample preparation , 2010 .

[35]  D. Ingram,et al.  Chronic caloric restriction partially protects against age-related alteration in serum metabolome , 2012, AGE.

[36]  Rafael Bargiela,et al.  Gut microbiota disturbance during antibiotic therapy: a multi-omic approach , 2012, Gut.

[37]  I. Wilson,et al.  Rapid and noninvasive metabonomic characterization of inflammatory bowel disease. , 2007, Journal of proteome research.

[38]  Amy M. Sheflin,et al.  Stool Microbiome and Metabolome Differences between Colorectal Cancer Patients and Healthy Adults , 2013, PloS one.

[39]  L. Garfinkel,et al.  U.S. cancer incidence, mortality and survival: 1973-1996. , 1999, Statistical bulletin.

[40]  U. Günther,et al.  Metabonomics of human fecal extracts characterize ulcerative colitis, Crohn’s disease and healthy individuals , 2014, Metabolomics.

[41]  C. Lee,et al.  Microbial community and metabolomic comparison of irritable bowel syndrome faeces , 2011, Journal of medical microbiology.

[42]  G. Hwang,et al.  1H NMR-based metabonomic assessment of probiotic effects in a colitis mouse model , 2010, Archives of pharmacal research.

[43]  Ting Wang,et al.  The gut microbiota as an environmental factor that regulates fat storage. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[44]  J. Gordon,et al.  How host-microbial interactions shape the nutrient environment of the mammalian intestine. , 2002, Annual review of nutrition.

[45]  A. Smilde,et al.  Large-scale human metabolomics studies: a strategy for data (pre-) processing and validation. , 2006, Analytical chemistry.

[46]  M. Lefevre,et al.  Broad scope method for creating humanized animal models for animal health and disease research through antibiotic treatment and human fecal transfer , 2014, Gut microbes.

[47]  Curtis J. Donskey,et al.  Metabolomics Analysis Identifies Intestinal Microbiota-Derived Biomarkers of Colonization Resistance in Clindamycin-Treated Mice , 2014, PloS one.

[48]  Lanjuan Li,et al.  Metabolomic analyses of faeces reveals malabsorption in cirrhotic patients. , 2013, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[49]  Daniel Monleón,et al.  Metabolite profiling of fecal water extracts from human colorectal cancer , 2009, NMR in biomedicine.

[50]  I. Wilson,et al.  LC-MS-based methodology for global metabolite profiling in metabonomics/metabolomics , 2008 .

[51]  I. Wilson,et al.  Within-day reproducibility of an HPLC-MS-based method for metabonomic analysis: application to human urine. , 2007, Journal of proteome research.

[52]  W. Sandborn,et al.  Inflammatory bowel disease: clinical aspects and established and evolving therapies , 2007, The Lancet.

[53]  E. Vaughan,et al.  1H NMR metabolite profiling of feces as a tool to assess the impact of nutrition on the human microbiome , 2008, NMR in biomedicine.

[54]  Joshua D. Knowles,et al.  Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry , 2011, Nature Protocols.

[55]  P. Cotter,et al.  Role of the gut microbiota in health and chronic gastrointestinal disease: understanding a hidden metabolic organ , 2013, Therapeutic advances in gastroenterology.

[56]  J. Alverdy,et al.  Diet creates metabolic niches in the "immature gut" that shape microbial communities. , 2011, Nutricion hospitalaria.

[57]  I. Wilson,et al.  Gut microorganisms, mammalian metabolism and personalized health care , 2005, Nature Reviews Microbiology.

[58]  M. Blasco,et al.  A metabolic signature predicts biological age in mice , 2013, Aging cell.

[59]  E. Chan,et al.  Global gas chromatography/time-of-flight mass spectrometry (GC/TOFMS)-based metabonomic profiling of lyophilized human feces. , 2013, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[60]  Joshua D. Knowles,et al.  Development of a robust and repeatable UPLC-MS method for the long-term metabolomic study of human serum. , 2009, Analytical chemistry.